Erratum: Identification of metabolically stable 5'-phosphate analogs that support single-stranded siRNA activity (Nucleic Acids Res (2015) 43:6 (2993–3011) (DOI:10.1093/nar/gkv162));Identification of metabolically stable 5′-phosphate analogs that support single-stranded siRNA activity

Nucleic Acids Research

Volumn 43, Issue 6, 2015, Pages 2993-3011

  Prakash, Thazha P ^a   Lima, Walt F ^a   Murray, Heather M ^a   Li, Wenyu ^a   Kinberger, Garth A ^a   Chappell, Alfred E ^a   Gaus, Hans ^a   Seth, Punit P ^a   Bhat, Balkrishen ^a   Crooke, Stanley T ^a   Swayze, Eric E ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; ARGONAUTE 2 PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PHOSPHATE; SINGLE STRANDED SMALL INTERFERING RNA; SMALL INTERFERING RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CONFORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ELECTROPORATION; GENE SILENCING; HELA CELL LINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; RNA STABILITY; STRUCTURE ACTIVITY RELATION; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BAGG ALBINO MOUSE; BINDING SITE; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN;

ANIMALS; APOLIPOPROTEIN C-III; ARGONAUTE PROTEINS; BASE SEQUENCE; BINDING SITES; CHOLESTEROL, LDL; HELA CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NUCLEIC ACID CONFORMATION; PHOSPHATES; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA STABILITY; RNA, MESSENGER; RNA, SMALL INTERFERING; TRIGLYCERIDES;

EID: 84942279838     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkx381     Document Type: Erratum

References (40)

1. Elbashir,S.M., Lendeckel,W. and Tuschl,T. (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev., 15, 188-200.
2. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498.
3. Kubowicz,P., Zelaszczyk,D. and Pekala,E. (2013) RNAi in clinical studies. Curr. Med. Chem., 20, 1801-1816.
4. DeVincenzo,J., Lambkin-Williams,R., Wilkinson,T., Cehelsky,J., Nochur,S., Walsh,E., Meyers,R., Gollob,J. and Vaishnaw,A. (2010) A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc. Natl. Acad. Sci. U.S.A., 107, 8800-8805.
5. Adams,D., Coelho,T., Suhr,O., Conceicao,I., Waddington-Cruz,M., Schmidt,H., Campistol,J., Pouget,J., Buades,J., Falzone,R. et al. (2013) In: 2013 Biennial Meeting of the Peripheral Nerve Society.St. Malo.
6. Tabernero,J., Shapiro,G.I., LoRusso,P.M., Cervantes,A., Schwartz,G.K., Weiss,G.J., Paz-Ares,L., Cho,D.C., Infante,J.R., Alsina,M. et al. (2013) First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov., 3, 406-417.
7. Bennett,C.F. and Swayze,E.E. (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol., 50, 259-293.
8. Lima,W.F., Murray,H., Nichols,J.G., Wu,H., Sun,H., Prakash,T.P., Berdeja,A.R., Gaus,H.J. and Crooke,S.T. (2009) Human Dicer binds short single-strand and double-strand RNA with high affinity and interacts with different regions of the nucleic acids. J. Biol. Chem., 284, 2535-2548.
9. Lima,W.F., Prakash,T. P., Murray,H.M., Kinberger,G.A., Li,W., Chappell,A.E., Li,C.S., Murray,S.F., Gaus,H., Seth,P. P. et al. (2012) Single-stranded siRNAs activate RNAi in animals. Cell, 150, 883-894.
10. Yu,D., Pendergraff,H., Liu,J., Kordasiewicz,H. B., Cleveland,D.W., Swayze,E.E., Lima,W.F., Crooke,S.T., Prakash,T.P. and Corey,D.R. (2012) Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell, 150, 895-908.
11. Prakash,T.P., Lima,W.F., Murray,H.M., Elbashir,S., Cantley,W., Foster,D., Jayaraman,M., Chappell,A.E., Manoharan,M., Swayze,E.E. et al. (2013) Lipid nanoparticles improve activity of single-stranded siRNA and gapmer antisense oligonucleotides in animals. ACS Chem. Biol., 8, 1402-1406.
12. Schirle,N.T. and MacRae,I.J. (2012) The crystal structure of human Argonaute2. Science, 336, 1037-1040.
13. Nakanishi,K., Weinberg,D.E., Bartel,D.P. and Patel,D.J. (2012) Structure of yeast Argonaute with guide RNA. Nature, 486, 368-374.
14. Wang,Y., Juranek,S., Li,H., Sheng,G., Tuschl,T. and Patel,D.J. (2008) Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature, 456, 921-926.
15. Wang,Y., Juranek,S., Li,H., Sheng,G., Wardle,G.S., Tuschl,T. and Patel,D.J. (2009) Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes. Nature, 461, 754-761.
16. Vickers,T.A., Lima,W.F., Wu,H., Nichols,J.G., Linsley,P.S. and Crooke,S.T. (2009) Off-target and a portion of target-specific siRNA mediated mRNA degradation is Ago2 'Slicer' independent and can be mediated by Ago1. Nucleic Acids Res., 37, 6927-6941.
17. Swayze,E.E., Siwkowski,A.M., Wancewicz,E.V., Migawa,M.T., Wyrzykiewicz,T.K., Hung,G., Monia,B.P. and Bennett,C.F. (2007) Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res., 35, 687-700.
18. Graham,M.J., Lee,R.G., Bell,T.A. III, Fu,W., Mullick,A.E., Alexander,V.J., Singleton,W., Viney,N., Geary,R., Su,J. et al. (2013) Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ. Res., 112, 1479-1490.
19. Haringsma,H.J., Li,J.J., Soriano,F., Kenski,D.M., Flanagan,W.M. and Willingham,A.T. (2012) mRNA knockdown by single strand RNA is improved by chemical modifications. Nucleic Acids Res., 40, 4125-4136.
20. Saha,A.K., Waychunas,C., Caulfield,T.J., Upson,D.A., Hobbs,C. and Yawman,A.M. (1995) 5′-methyl-DNA - a new oligonucleotide analog: synthesis and biochemical properties. J. Org. Chem., 60, 788-789.
21. Seth,P.P., Allerson,C.R., Siwkowski,A., Vasquez,G., Berdeja,A., Migawa,M.T., Gaus,H., Prakash,T.P., Bhat,B. and Swayze,E.E. (2010) Configuration of the 5′-methyl group modulates the biophysical and biological properties of locked nucleic acid (LNA) oligonucleotides. J. Med. Chem., 53, 8309-8318.
22. Prakash,T.P., Allerson,C.R., Dande,P., Vickers,T.A., Sioufi,N., Jarres,R., Baker,B.F., Swayze,E.E., Griffey,R.H. and Bhat,B. (2005) Positional effect of chemical modifications on short interference RNA activity in Mammalian cells. J. Med. Chem., 48, 4247-4253.
23. Matulic-Adamic,J., Haeberli,P. and Usman,N. (1995) Synthesis of 5″-deoxy-5′-difluoromethyl phosphonate nucleotide analogs. J. Org. Chem., 60, 2563-2569.
24. Engel,R. (1977) Phosphonates as analogues of natural phosphates. Chem. Rev., 77, 349-367.
25. Blackburn,G.M. and Ingleson,D. (1980) The dealkylation of phosphate and phosphonate esters by iodotrimethylsilane: a mild and selective procedure. J. Chem. Soc. , 1, 1150-1153.
26. Blackburn,G.M. and Kent,D.E. (1986) Synthesis of α- and γ-fluoroalkylphosphonates. J. Chem. Soc., 1, 913-917.
27. Wnuk,S.F. and Robins,M.J. (1996) Stannyl radical-mediated cleavage of π-deficient heterocyclic sulfones. Synthesis of α-fluoro esters and the first homonucleoside α-fluoromethylene phosphonate1. J. Am. Chem. Soc., 118, 2519-2520.
28. Or,Y.S., Ying,L., Peng,X., Wang,C. and Qiu,Y.-L. (2009) Application: US Patent No. 2009-434146, 20090274686.
29. Wang,G., Sakthivel,K., Rajappan,V., Bruice,T.W., Tucker,K., Fagan,P., Brooks,J.L., Hurd,T., Leeds,J.M. and Cook,P.D. (2004) Synthesis of azole nucleoside 5′-monophosphate mimics (P1Ms) and their inhibitory properties of IMP dehydrogenases. Nucleosides Nucleotides Nucleic Acids, 23, 317-337.
30. Prakash,T.P., Prhavc,M., Eldrup,A.B., Cook,P.D., Carroll,S.S., Olsen,D.B., Stahlhut,M.W., Tomassini,J.E., MacCoss,M., Galloway,S.M. et al. (2005) Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5′-monophosphates as inhibitors of hepatitis C virus RNA replication. J. Med. Chem., 48, 1199-1210.
31. Myers,T.C., Nakamura,K. and Danielzadeh,A.B. (1965) Phosphonic acid analogs of nucleoside phosphates. III. The synthesis of adenosine 5′-methylenediphosphonate, a phosphonic acid analog of adenosine 5′-diphosphate. J. Org. Chem., 30, 1517-1520.
32. Wang,J., Verbeure,B., Luyten,I., Lescrinier,E., Froeyen,M., Hendrix,C., Rosemeyer,H., Seela,F., Van Aerschot,A. and Herdewijn,P. (2000) Cyclohexene nucleic acids (CeNA): serum stable oligonucleotides that activate RNase H and increase duplex stability with complementary RNA. J. Am. Chem. Soc., 122, 8595-8602.
33. Seth,P.P., Allerson,C.R., Berdeja,A., Siwkowski,A., Pallan,P.S., Gaus,H., Prakash,T.P., Watt,A.T., Egli,M. and Swayze,E.E. (2010) An exocyclic methylene group acts as a bioisostere of the 2′-oxygen atom in LNA. J. Am. Chem. Soc., 132, 14942-14950.
34. Kumar,T.S., Zhou,S.-Y., Joshi,B.V., Balasubramanian,R., Yang,T., Liang,B.T. and Jacobson,K.A. (2010) Structure-activity relationship of (N)-methanocarba phosphonate analogues of 5′-AMP as cardioprotective agents acting through a cardiac P2X receptor. J. Med. Chem., 53, 2562-2576.
35. Jung,K.-Y., Hohl,R.J., Wiemer,A.J. and Wiemer,D.F. (2000) Synthesis of phosphonate derivatives of uridine, cytidine, and cytosine arabinoside. Bioorg. Med. Chem., 8, 2501-2509.
36. Meurillon,M., Gallier,F., Peyrottes,S. and Périgaud,C. (2009) Developing an efficient route to the synthesis of nucleoside 1-alkynylphosphonates. Tetrahedron, 65, 6039-6046.
37. Gallier,F., Alexandre,J.A.C., El Amri,C., Deville-Bonne,D., Peyrottes,S. and Périgaud,C. (2011) 5′,6′-nucleoside phosphonate analogues architecture: synthesis and comparative evaluation toward metabolic enzymes. ChemMedChem, 6, 1094-1106.
38. Blackburn,G.M., Kent,D.E. and Kolkmann,F. (1984) The synthesis and metal binding characteristics of novel, isopolar phosphonate analogs of nucleotidesIssue, J. Chem. Soc., 1, 1119-1125.
39. Halazy,S., Ehrhard,A. and Danzin,C. (1991) 9-(Difluorophosphonoalkyl)guanines as a new class of multisubstrate analog inhibitors of purine nucleoside phosphorylase. J. Am. Chem. Soc., 113, 315-317.
40. Martinez,J., Patkaniowska,A., Urlaub,H., Luhrmann,R. and Tuschl,T. (2002) Single-stranded antisense SiRNAs guide target RNA cleavage in RNAi. Cell, 110, 563-574.